These findings increase the likelihood that the peripheral neuropathy symptoms caused by DLK inhibition are due to dysregulated cytoskeletal integrity and/or axonal transport in DRG sensory neurons themselves. Here, MAP3K12 is linked to peripheral neuropathy.